The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.
A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more people with low to intermediate suspicion in the first place. The ...